InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: None

Saturday, 11/13/2021 11:02:58 AM

Saturday, November 13, 2021 11:02:58 AM

Post# of 44690
What VIP Does

Regulates Cortisol and Circadian Rhythms

VIP is a hormone produced in the hypothalamus of the brain, and it acts on the HPA Axis: the “stress” axis of the hypothalamus, pituitary, and adrenal glands to regulate adrenal hormone production and release. This means everything downstream from the adrenals improves, including cortisol, DHEA (the precursor to sex hormones) and aldosterone, which regulates fluid volume in conjunction with ADH.

Data suggests that VIP also directly stimulates production of the “core” stress hormone too: norepinephrine. For someone in constant fight-or-flight, you might not think this is a good thing—but these people are actually depleted in catecholamines like norepinephrine more often than not, and increasing overall stores of it can be very helpful.

The HPA axis has a strong effect on circadian rhythms, so it helps regulate sleep cycles and melatonin as well.

Improves Digestion

Since out-of-whack cortisol levels lead to a thinned gut lining and a predisposition to food sensitivities, VIP also helps to repair leaky gut. This is also in part because VIP directly increases blood flow to the gut, improves gut motility, and stimulates release of enzymes, stomach acid, and bile in the gut.

Improves Immune Tolerance

Hypersensitive individuals who seem to react poorly to everything know how important this one is. Specifically, this refers to VIP decreasing Th1 autoimmune responses and promoting Th2 (allergic) responses instead, since this is always a trade-off.

But ultimately, VIP lowers most inflammatory cytokines (those second messengers of the immune system that trigger it to jump into action) and encourage production of the T regulatory cells that help promote immune tolerance.

https://www.drlaurendeville.com/articles/vip-for-biotoxin-illness/

The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025. An autoimmune disease causes the immune system to destroy its own body tissue.

https://www.alliedmarketresearch.com/autoimmune-disease-therapeutics-market